TP53 and gastric cancer: Recently, comprehensive molecular characterization of GC presents several distinct molecular features and epigenetic alterations of EBVaGC, including lack of TP53 mutations, frequent PI3K mutations, and a high degree of CpG methylation in the tumor cell genome [113].